Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,844 | 5,831 | 4,039 | 13,125 | 8,711 |
| Depreciation Amortization | 560 | 375 | 189 | 755 | 566 |
| Income taxes - deferred | 0 | N/A | N/A | -3,170 | N/A |
| Accounts receivable | 468 | 1,263 | 303 | -790 | 876 |
| Other Working Capital | -29,333 | -20,383 | -10,807 | -45,171 | -34,772 |
| Other Operating Activity | 2,613 | 1,471 | 301 | 2,062 | -7 |
| Operating Cash Flow | $-15,848 | $-11,443 | $-5,975 | $-33,189 | $-24,626 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,737 | 11,550 | 5,995 | -270 | 24,362 |
| PPE Investments | -79 | -40 | -25 | 33,450 | -98 |
| Investing Cash Flow | $15,658 | $11,510 | $5,970 | $33,180 | $24,264 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | N/A | N/A | -3 | -3 |
| Common Stock Issued | 22 | 1 | N/A | 3 | 2 |
| Other Financing Activity | 129 | 0 | 0 | 145 | 145 |
| Financing Cash Flow | $151 | $1 | $N/A | $145 | $144 |
| Beginning Cash Position | 1,442 | 1,442 | 1,442 | 1,306 | 1,306 |
| End Cash Position | 1,403 | 1,510 | 1,437 | 1,442 | 1,088 |
| Net Cash Flow | $-39 | $68 | $-5 | $136 | $-218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,848 | -11,443 | -5,975 | -33,189 | -24,626 |
| Capital Expenditure | -79 | -40 | -25 | -148 | -98 |
| Free Cash Flow | -15,927 | -11,483 | -6,000 | -33,337 | -24,724 |